Bimekizumab showed durable four-year psoriasis clearance with mechanistic insights into immune memory modulation. Read more ...

Early-life sugar rationing was associated with reduced heart failure risk decades later. Learn how infant nutrition shaped ...

New research shows risankizumab delivers long-term psoriasis control, with OCT revealing reduced subclinical inflammation.

The Office of Inspector General's bulletin provides a framework for pharma companies selling prescription ...

Patient Integration is increasingly urgent in oncology research, as growing complexity fuels demand for patient-level translation and outcomes that reflect real needs across preclinical and clinical ...

Mobile app engagement in an eight week mHealth program was tied to meaningful pain improvement in adults with chronic pain ...

Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and ...

Pascal Soriot, CEO, AZ, hailed the investment as the start of "an exciting next chapter" for the company in China.

Healthy adults trained to upregulate reward circuitry using neurofeedback showed stronger immune responses to HBV vaccination. Read more.

Body composition and inflammation significantly affect oesophageal cancer survival following immunotherapy. Read more.

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these ...

A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the cardiovascular risk.